The objective of the project is to develop mathematical models of HPV/cytology based cervical cancer screening protocols for the evaluation of the health and cost benefits for EU states. The long-term performance of a combined HPV/cytology regimen on a country-specific basis is established from screening trials that rerunning in 6 different European countries and combined at a European level. In addition the costs of existing cervical cancer screening programs and related healthcare actions are collected. These data will be combined in mathematical models used to evaluate clinical outcomes and healthcare cost benefits for different scenarios. The outcome of this analysis will be used to develop interim, fully coasted, country- and EU-specific cervical cancer screening protocols, whichwill be used to start an informed debate leading to the development of a new European consensus policy for screening of cervical cancer.
Funding SchemeCSC - Cost-sharing contracts
WC2A 3PX London
3000 DR Rotterdam
08907 Hospitalet Del Llobregat
205 02 Malmoe